Nicholas Company’s Globus Medical GMED Stock Holding History

Nicholas Company’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7M	Sell	249,329 -120	-0%	-$10.2K	0.36%	64
2026 Q1	$21.5M	Sell	249,449 -58,272	-19%	-$5.23M	0.42%	59
2025 Q4	$26.9M	Sell	307,721 -52,370	-15%	-$3.97M	0.47%	54
2025 Q3	$20.6M	Hold	360,091	–	–	0.35%	71
2025 Q2	$21.3M	Buy	360,091 +80	+0%	+$5.17K	0.36%	72
2025 Q1	$26.4M	Buy	360,011 +140	+0%	+$11.6K	0.46%	61
2024 Q4	$29.8M	Sell	359,871 -125	-0%	-$9.86K	0.48%	62
2024 Q3	$25.8M	Sell	359,996 -195	-0.1%	-$13.8K	0.42%	64
2024 Q2	$24.7M	Sell	360,191 -2,570	-0.7%	-$154K	0.41%	67
2024 Q1	$19.5M	Sell	362,761 -2,760	-0.8%	-$148K	0.32%	87
2023 Q4	$19.5M	Buy	365,521 +4,855	+1%	+$237K	0.34%	82
2023 Q3	$17.9M	Buy	360,666 +127,816	+55%	+$7.15M	0.36%	79
2023 Q2	$13.9M	Sell	232,850 -2,805	-1%	-$160K	0.27%	97
2023 Q1	$13.3M	Buy	235,655 +18,475	+9%	+$1.18M	0.27%	102
2022 Q4	$16.1M	Hold	217,180	–	–	0.35%	83
2022 Q3	$12.9M	Buy	217,180 +16,575	+8%	+$998K	0.3%	93
2022 Q2	$11.3M	Buy	200,605 +16,000	+9%	+$1.05M	0.25%	103
2022 Q1	$13.6M	Buy	184,605 +4,685	+3%	+$326K	0.24%	107
2021 Q4	$13M	Sell	179,920 -20	-0%	-$1.45K	0.21%	119
2021 Q3	$13.8M	Sell	179,940 -20	-0%	-$1.61K	0.24%	112
2021 Q2	$14M	Sell	179,960 -35	-0%	-$2.49K	0.25%	116
2021 Q1	$11.1M	Sell	179,995 -1,250	-0.7%	-$79.2K	0.21%	124
2020 Q4	$11.8M	Buy	+181,245	New	+$10.4M	0.22%	122
2017 Q1	–	Sell	-170	Closed	-$4K	–	217
2016 Q4	$4K	Sell	170 -101,550	-100%	-$2.31M	﹤0.01%	212
2016 Q3	$2.29M	Sell	101,720 -20,470	-17%	-$481K	0.05%	193
2016 Q2	$2.91M	Hold	122,190	–	–	0.06%	179
2016 Q1	$2.9M	Buy	122,190 +21,400	+21%	+$523K	0.06%	174
2015 Q4	$2.8M	Hold	100,790	–	–	0.05%	182
2015 Q3	$2.08M	Sell	100,790 -60,975	-38%	-$1.54M	0.04%	190
2015 Q2	$4.15M	Buy	161,765 +190	+0.1%	+$4.81K	0.07%	156
2015 Q1	$4.08M	Hold	161,575	–	–	0.08%	166
2014 Q4	$3.84M	Sell	161,575 -25,260	-14%	-$559K	0.08%	176
2014 Q3	$3.67M	Buy	186,835 +15,285	+9%	+$314K	0.09%	161
2014 Q2	$4.1M	Sell	171,550 -200	-0.1%	-$4.82K	0.1%	158
2014 Q1	$4.57M	Sell	171,750 -26,325	-13%	-$626K	0.11%	144
2013 Q4	$4M	Hold	198,075	–	–	0.1%	171
2013 Q3	$3.46M	Buy	198,075 +19,700	+11%	+$341K	0.09%	187
2013 Q2	$3.01M	Buy	+178,375	New	+$2.75M	0.09%	192

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Nicholas Company's GMED Position: Q2 2026 in Review

Nicholas Company reduced its Globus Medical (GMED) stake by 0.05% in Q2 2026, selling an estimated $10.2K and leaving 249,329 shares worth $19.7M. The position accounts for 0.36% of the portfolio, ranked #64.

Nicholas Company first reported a position in GMED in Q2 2013 and has held it in 38 quarters since. The position peaked at $29.8M in Q4 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Nicholas Company held 249,329 shares of Globus Medical worth $19.7M as of Q2 2026.
Nicholas Company sold 120 Globus Medical shares in Q2 2026, an estimated $10.2K.
Globus Medical made up 0.36% of Nicholas Company's portfolio in Q2 2026, its #64 holding.
Nicholas Company first reported a position in Globus Medical in Q2 2013 and has held it in 38 quarters since.
Nicholas Company's Globus Medical position peaked at $29.8M in Q4 2024.
596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.